2,871 Shares in Integer Holdings Co. (NYSE:ITGR) Purchased by Farringdon Capital Ltd.

Farringdon Capital Ltd. purchased a new stake in Integer Holdings Co. (NYSE:ITGR - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund purchased 2,871 shares of the medical equipment provider's stock, valued at approximately $380,000.

Other institutional investors and hedge funds have also bought and sold shares of the company. Versant Capital Management Inc grew its position in Integer by 98.4% in the fourth quarter. Versant Capital Management Inc now owns 369 shares of the medical equipment provider's stock valued at $49,000 after acquiring an additional 183 shares during the last quarter. KBC Group NV increased its holdings in Integer by 83.3% in the 4th quarter. KBC Group NV now owns 1,598 shares of the medical equipment provider's stock worth $212,000 after purchasing an additional 726 shares in the last quarter. Lord Abbett & CO. LLC boosted its stake in shares of Integer by 3.5% during the third quarter. Lord Abbett & CO. LLC now owns 290,120 shares of the medical equipment provider's stock valued at $37,716,000 after purchasing an additional 9,754 shares in the last quarter. Tributary Capital Management LLC increased its stake in shares of Integer by 0.8% in the fourth quarter. Tributary Capital Management LLC now owns 287,525 shares of the medical equipment provider's stock valued at $38,103,000 after buying an additional 2,289 shares during the period. Finally, Principal Financial Group Inc. grew its holdings in Integer by 3.9% during the 4th quarter. Principal Financial Group Inc. now owns 182,267 shares of the medical equipment provider's stock worth $24,154,000 after acquiring an additional 6,905 shares during the last quarter. Institutional investors own 99.29% of the company's stock.

Wall Street Analysts Forecast Growth

A number of analysts recently weighed in on ITGR shares. Raymond James started coverage on Integer in a report on Friday, March 28th. They issued an "outperform" rating and a $145.00 price objective for the company. Benchmark raised their price objective on shares of Integer from $140.00 to $150.00 and gave the stock a "buy" rating in a research report on Friday, February 21st. KeyCorp lowered their target price on shares of Integer from $154.00 to $145.00 and set an "overweight" rating on the stock in a report on Monday. Oppenheimer lowered Integer from an "outperform" rating to a "market perform" rating in a report on Friday, February 21st. Finally, Truist Financial dropped their target price on shares of Integer from $163.00 to $140.00 and set a "buy" rating on the stock in a research report on Friday, April 11th. Two equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus price target of $145.00.

Integer Price Performance

ITGR traded up $3.39 during midday trading on Wednesday, hitting $121.37. The stock had a trading volume of 90,685 shares, compared to its average volume of 347,329. The company has a market cap of $4.23 billion, a P/E ratio of 36.12, a price-to-earnings-growth ratio of 1.72 and a beta of 1.09. Integer Holdings Co. has a 1 year low of $104.93 and a 1 year high of $146.36. The business has a fifty day moving average of $120.73 and a 200 day moving average of $130.42. The company has a debt-to-equity ratio of 0.62, a quick ratio of 2.09 and a current ratio of 2.95.

Integer (NYSE:ITGR - Get Free Report) last released its earnings results on Thursday, February 20th. The medical equipment provider reported $1.43 EPS for the quarter, missing the consensus estimate of $1.46 by ($0.03). Integer had a net margin of 6.92% and a return on equity of 11.65%. The business had revenue of $449.50 million for the quarter, compared to the consensus estimate of $446.28 million. As a group, equities analysts forecast that Integer Holdings Co. will post 6.01 earnings per share for the current fiscal year.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.